Health Law Diagnosed — Transactions Part 2: The Role of Health Regulatory Diligence and How to Prepare for a Sell-Side Transaction [PODCAST]
Friday, March 25, 2022
Print Mail Download info_icon_img/>i

Health regulatory diligence has the ability to make or break a deal. Listen to hear about our team’s firsthand experience in the importance of conducting health regulatory diligence and best practices in preparing for a sell-side transaction.

©1994-2025 Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. All Rights Reserved.

Current Public Notices

Post Your Public Notice Today!

PUBLIC NOTICE OF UCC ARTICLE 9 SALE: CCP Mezzanine Nashville I, LLC
Published: 24 April, 2025
PUBLIC NOTICE OF ASSIGNEE SALE: Starved Rock Wood Products LLC
Published: 24 April, 2025
PUBLIC NOTICE OF AUCTION OF ASSETS: BOKKSU INC. AND JAPAN CRATE ACQUISITION LLC
Published: 21 April, 2025
PUBLIC NOTICE OF DISPOSITION OF COLLATERAL: GeneralHealth Group Inc.
Published: 8 April, 2025
PUBLIC NOTICE OF UCC ARTICLE 9 SALE: LQD LOANS TWO, LCC
Published: 7 April, 2025
PUBLIC NOTICE OF RECEIVERS SALE: Gladstone Food Products
Published: 7 April, 2025
PUBLIC NOTICE OF CHAPTER 11 SALE: S&G Hospitality, INC
Published: 1 April, 2025
PUBLIC NOTICE OF RECEIVER’S SALE: LANDSCAPING SUBCONTRACTOR
Published: 31 March, 2025
PUBLIC NOTICE OF 363 SALE: Elmer Buchta Trucking
Published: 31 March, 2025
PUBLIC NOTICE OF UCC ARTICLE 9 SALE: PHILLIPS AMSTERDAM II LLC
Published: 31 March, 2025
Discover more public notices

Current Legal Analysis

More from Mintz

OIG Issues Another Favorable Advisory Opinion on Patient Recruitment Efforts by Community Health Centers
by: Rachel E. Yount
HHS Restructuring and Workforce Reductions – Key Implications for the Health Care Industry
by: Joanne S. Hawana , Jean D. Mancheno
A Texas Federal Court Sides with Laboratories, But There May Be Unintended Consequences for FDA
by: Benjamin M. Zegarelli , Joanne S. Hawana
Seller Considerations When Negotiating a Letter of Intent
by: Jeremy D. Glaser , Stephen M. Callegari
New York Department of Health Issues Long-Awaited FAQs for New York’s Disclosure of Material Transactions Law
by: Jean D. Mancheno , Cody Keetch
SEC Provides Further Clarity in Rule 506(c) Offerings
by: Daniel I. DeWolf , Samuel Asher Effron
SEC Abandons Climate Disclosure Rule
by: Jacob H. Hupart
CMS’s ACA Marketplace Integrity and Affordability Proposed Rule – What it may mean for Health Plans
by: Lauren M. Moldawer , Xavier G. Hardy
What to Take Away from CMMI’s Early Termination of Four Demonstration Models
by: Xavier G. Hardy
FDA’s Backup LDT Enforcement Method: Specimen Collection Kits
by: Benjamin M. Zegarelli , Joanne S. Hawana
Greenwashing Lawsuit Against Lululemon Dismissed by Federal Court
by: Jacob H. Hupart
Red State AGs Sue New York State in Challenge to Climate Change Superfund Act
by: Jacob H. Hupart
FDA Continues Push to Improve Food Labeling Practices in the United States
by: Joanne S. Hawana , Jean D. Mancheno
A New Era for Crypto Regulation & Innovation? The Crypto Executive Order, a Rebooted SEC Crypto Task Force & the Journey Ahead
by: David G. Adams , Frank L. Gerratana
Biden Administration's DOL Rule Permitting ESG Investments Survives Legal Challenge
by: Jacob H. Hupart

Upcoming Events

 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters